Anticancer Agents. Frontiers in Cancer Chemotherapy

[Prohibitive]

Anticancer Agents. Frontiers in Cancer Chemotherapy By Iwao Ojima, Gregory D. Vite, and Karl-Heinz Altmann (Eds.)
2001 | 375 Pages | ISBN: 084123745X | PDF | 33 MB

Content: Cancer drug discovery and development : new paradigms for a new millennium / E.A. Sausville ... [et al.] Evolutionary biosynthesis of anticancer drugs / George R. Pettit Some recent developments in the synthesis and structure-activity relationship of novel taxanes / John F. Kadow ... [et al.] New generation taxoids and hybrids of microtubule-stabilizing anticancer agents / Iwao Ojima ... [et al.] Discodermolide and taxol : a synergistic drug combination in human carcinoma cell lines / Susan Band Horwitz ... [et al.] Highly efficient semisynthesis of biologically active epothilone derivatives / Gregory D. Vite ... [et al.] Synthetic and semisynthetic analogs of epothilones : chemistry and biological activity / Karl-Heinz Altmann ... [et al.] Synthesis and biological activity of epothilones / Ulrich Klar ... [et al.] Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou Synthesis and structure-activity relationship studies of cryptophycins : a novel class of potent antimitotic antitumor depsipeptides / Chuan Shih ... [et al.] Farnesyltransferase inhibitors as potential anticancer agents / J.B. Gibbs ... [et al.] Farnesyltransferase inhibitors : from squalene synthase inhibitors to the clinical agent BMS-214662 / John T. Hunt Inhibiting farnesyl protein transferase with Sch-66336 : potentially a selective noncytotoxic therapy for human cancer / A.G. Taveras ... [et al.] Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti ... [et al.] STI571 : a new treatment modality for CML? / Jürg Zimmermann, Pascal Furet, and Elisabeth Buchdunger The discovery and development of second-generation matrix metalloproteinase inhibitors for the treatment of cancer / Andy Baxter and John Montana Prospects for antiangiogenic therapies based upon VEGF inhibition / Pascal Furet and Paul W. Manley Carbohydrate-based tumor antigens as antitumor vaccine agents / Jennifer R. Allen and Samuel J. Danishefsky Drugs to enhance the therapeutic potency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Blättler and Ravi V.J. Chari.

DOWNLOAD
(Buy premium account for maximum speed and resuming ability)

http://nitroflare.com/view/4FFE3F7CB5FDEC2/axgjb.rar

https://rapidgator.net/file/b49c0cffb7fbae1427ff31b71763af87/axgjb.rar

http://turbobit.net/15z2jljwiv3y/axgjb.rar.html